Rosário Souza, Mariana doSilva da Paz, Wandklebsondos Santos Sales, Vinícius BarbosaHilario de Jesus, Gleidson Felipedos Santos Tavares, DéboraAlmeida Lima, Shirley V.M.Lopes Sousa, Álvaro FranciscoVieira de Melo, EnaldoFeliciano do Carmo, RodrigoFreire de Souza, Carlos DornelsBezerra-Santos, Márcio2023-02-032023-02-032022-09-061663-9812PURE: 50788022PURE UUID: 84d0d846-ab4d-4d90-82da-1ba0c695c717Scopus: 85138325377PubMedCentral: PMC9486810WOS: 000856049000001http://hdl.handle.net/10362/148646Publisher Copyright: © 2022 Rosário Souza, Silva da Paz, dos Santos Sales, Hilario de Jesus, dos Santos Tavares, Almeida Lima, Lopes Sousa, Vieira de Melo, Feliciano do Carmo, Freire de Souza and Bezerra-Santos.In the published article, there was an error in the Funding statement. The manuscript was published without due mention of the funding agency. The correct Funding statement appears below. “Global Health and Tropical Medicine, Instituto de Higiene e Medicina Tropical, Universidade NOVA de Lisboa, Portugal, ref. UID/04413/2020.” In addition, the article was published without including the acknowledgments. The correct Acknowledgments statement appears below.496223engCOVID-19COVID-19 pandemicend TB strategyglobal healthtuberculosisRA0421 Public health. Hygiene. Preventive MedicineQR MicrobiologyPharmacologyPharmacology (medical)MicrobiologySDG 3 - Good Health and Well-beingSDG 10 - Reduced InequalitiesCorrigendumother10.3389/fphar.2022.999301Impact of the COVID-19 pandemic on the diagnosis of tuberculosis in Brazil: Is the WHO end TB strategy at risk?(Front. Pharmacol., (2022), 13, (891711), 10.3389/fphar.2022.891711)https://www.scopus.com/pages/publications/85138325377